Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual antiplatelet therapy versus oral anticoagulation after TAVI to prevent cerebral embolism
2011-005784-24Phase 4Active
- Sponsor
- Andres Iñiguez Romo
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clopidogrel, aspirin and acenocoumarol in cerebral sinovenous thrombosis (CSVT) and systemic embolism (2 arms), sponsored by Andres Iñiguez Romo. Primary endpoint: Incidence of major vascular events. Started Mar 2012; status: active.
02
Drugs
clopidogrelaspirinacenocoumarol
03
Conditions
cerebral sinovenous thrombosis (CSVT)systemic embolism
Beyond the preview
Go deeper on 2011-005784-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005784-24.